Application of human RNase P normalization for the realistic estimation of SARS-CoV-2 viral load in wastewater: A perspective from Qatar wastewater surveillance

por El-Malah, Shimaa S., Saththasivam, Jayaprakash, Jabbar, Khadeeja Abdul, K.K., Arun, Gomez, Tricia A., Ahmed, Ayeda A., Mohamoud, Yasmin A., Malek, Joel A., Abu Raddad, Laith J., Abu Halaweh, Hussein A., Bertollini, Roberto, Lawler, Jenny, Mahmoud, Khaled A.
Publicado 2022

COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar

por Saththasivam, Jayaprakash, El-Malah, Shimaa S., Gomez, Tricia A., Jabbar, Khadeeja A., Remanan, Reshma, Krishnankutty, Arun K., Ogunbiyi, Oluwaseun, Rasool, Kashif, Ashhab, Sahel, Rashkeev, Sergey, Bensaad, Meryem, Ahmed, Ayeda A., Mohamoud, Yasmin A., Malek, Joel A., Abu Raddad, Laith J., Jeremijenko, Andrew, Abu Halaweh, Hussein A., Lawler, Jenny, Mahmoud, Khaled A.
Publicado 2021

Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months

por Abu-Raddad, Laith J., Chemaitelly, Hiam, Malek, Joel A., Ahmed, Ayeda A., Mohamoud, Yasmin A., Younuskunju, Shameem, Al Kanaani, Zaina, Al Khal, Abdullatif, Al Kuwari, Einas, Butt, Adeel A., Coyle, Peter, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul Rahim, Hanan F., Yassine, Hadi M., Al Kuwari, Mohamed G., Al Romaihi, Hamad Eid, Al-Thani, Mohamed H., Bertollini, Roberto
Publicado 2021

Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting

por Abu-Raddad, Laith J, Chemaitelly, Hiam, Malek, Joel A, Ahmed, Ayeda A, Mohamoud, Yasmin A, Younuskunju, Shameem, Ayoub, Houssein H, Al Kanaani, Zaina, Al Khal, Abdullatif, Al Kuwari, Einas, Butt, Adeel A, Coyle, Peter, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul Rahim, Hanan F, Yassine, Hadi M, Al Kuwari, Mohamed G, Al Romaihi, Hamad Eid, Al-Thani, Mohamed H, Bertollini, Roberto
Publicado 2020

SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

por Abu-Raddad, Laith J., Chemaitelly, Hiam, Coyle, Peter, Malek, Joel A., Ahmed, Ayeda A., Mohamoud, Yasmin A., Younuskunju, Shameem, Ayoub, Houssein H., Al Kanaani, Zaina, Al Kuwari, Einas, Butt, Adeel A., Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul Rahim, Hanan F., Nasrallah, Gheyath K., Yassine, Hadi M., Al Kuwari, Mohamed Ghaith, Al Romaihi, Hamad Eid, Al-Thani, Mohamed H., Al Khal, Abdullatif, Bertollini, Roberto
Publicado 2021

Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study

por Abu-Raddad, Laith J., Chemaitelly, Hiam, Ayoub, Houssein H., Coyle, Peter, Malek, Joel A., Ahmed, Ayeda A., Mohamoud, Yasmin A., Younuskunju, Shameem, Tang, Patrick, Al Kanaani, Zaina, Al Kuwari, Einas, Butt, Adeel A., Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul Rahim, Hanan F., Nasrallah, Gheyath K., Yassine, Hadi M., Al Kuwari, Mohamed Ghaith, Al Romaihi, Hamad Eid, Al-Thani, Mohamed H., Al Khal, Abdullatif, Bertollini, Roberto
Publicado 2021

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar

por Benslimane, Fatiha M., Al Khatib, Hebah A., Al-Jamal, Ola, Albatesh, Dana, Boughattas, Sonia, Ahmed, Ayeda A, Bensaad, Meryem, Younuskunju, Shameem, Mohamoud, Yasmin A., Al Badr, Mashael, Mohamed, Abdalla A., El-Kahlout, Reham A., Al-Hamad, Tasneem, Elgakhlab, Dina, Al-Kuwari, Fatima H., Saad, Chadi, Jeremijenko, Andrew, Al-Khal, Abdullatif, Al-Maslamani, Muna A., Bertollini, Roberto, Al-Kuwari, Einas A., Al-Romaihi, Hamad E., Al-Marri, Salih, Al-Thani, Mohammed, Badji, Radja M., Mbarek, Hamdi, Al-Sarraj, Yasser, Malek, Joel A., Ismail, Said I., Abu-Raddad, Laith J., Coyle, Peter V., Thani, Asmaa A. Al, Yassine, Hadi M.
Publicado 2021